
4 minute read
References
south AsiA vAccinAtes
economic activity. The increase in economic activity for each vaccination group (measured by consumption) factors into the valuation of vaccinating that group.
For historical consumption data, we rely on the Centre for Monitoring Indian Economy’s Consumer Pyramids Database, a population-representative panel data set with monthly observations sampling 174,000 households in India. Since this data is at the household level, we disaggregate the household level data to age bins using the OECD’s standard formula for this problem.
References
Alesina, A., R. Baqir, and W. Easterly. 1999. “Public Goods and Ethnic Divisions.”The
Quarterly Journal of Economics,114 (4) 1243-1284.
Al-Mohaithef, M., and B. K. Padhi. 2020. “Determinants of COVID-19 Vaccine
Acceptance in Saudi Arabia: A Web-Based National Survey.” Journal of
Multidisciplinary Healthcare,13 (20): 1657-1663.
Andersen, C., Andrews, K., Cain, J. and Tandon, A. 2021. “South Asia Vaccinates against COVID-19: Health System and Health Financing Considerations.”
Banerjee, A. V., E. Duflo, R. Glennerster, and D. Kothari. 2010. “Improving Immunisation
Coverage in Rural India: Clustered Randomised Controlled Evaluation of
Immunisation Campaigns With and Without Incentives.”BMJ,340.
Banerjee, A., L. Iyer, and R. Somanathan. 2007. “Public Action for Public Goods.” NBER Working Paper 12911 National Bureau of Economic Research, Cambridge, MA.
Betsch, C., R. Böhm, and G. B. Chapman. 2015. “Using Behavioral Insights to
Increase Vaccination Policy Effectiveness.” Policy Insights from the Behavioral and Brain Sciences, 2 (1): 61-73.
Bussolo, M., A. Kotia, and S. Siddharth. 2021 “Workers at Risk: Panel Data Evidence on the COVID-19 Labor Market Crisis in India.” Policy Research Working Paper 9584, World Bank, Washington, DC.
Castillo, J. C., A. Ahuja, S. Athey, A. Baker, E. Budish, T. Chipty, R. Glennerster, et al. 2021. “Market Design to Accelerate COVID-19 Vaccine Supply.” Science 371(6534): 1107-1109.
SOUTH ASIA VACCINATES
Demombynes, G. 2020. “COVID-19 Age-Mortality Curves Are Flatter in Developing Countries.” Policy Research Working Paper 9313. World Bank, Washington, DC.
Demographic and Health Surveys Program. 2018. “Pakistan Demographic and
Health Survey 2017-2018.”
Easterly, W. and R. Levine. 1997. “Africa’s Growth Tragedy: Policies and Ethnic
Divisions.”The Quarterly Journal of Economics,112 (4): 1203-1250.
Gavi the Vaccine Alliance. 2020. “Are Vaccines a Global Public Good?”
Gauri, V., and P. Khaleghian. 2002. “Immunization in Developing Countries: Its
Political and Organizational Determinants.” Policy Research Working Paper 2769. World Bank, Washington, DC.
Giorgio, L. D. 2019. “Health Sector Inputs to the Pakistan Systematic Country
Diagnostic.” World Bank Group, Washington DC.
i Arolas, H. P., E. Acosta, G. López-Casasnovas, A. Lo, C. Nicodemo, T. Riffe, and
M. Myrskylä. 2021. “Years of Life Lost to COVID-19 in 81 Countries.” Scientific
Reports, 11(1): 1-6.
Jarrett, C., R. Wilson, M. O’Leary, E. Eckersberger, and H. J. Larson. SAGE Working
Group on Vaccine Hesitancy. 2014. Vaccine. “Strategies for Addressing
Vaccine Hesitancy–A Systematic Review.” 33 (34): 4180-4190.
Koff, W. and S. Berkley. 2021. “A Universal Coronavirus Vaccine.” Science, 371(6531): 759.
Kumar, G. 2020 and S. Gupta. “Assessment of Cold Chain Equipments and Their
Management in Government Health Facilities in a District of Delhi: A Cross-
Sectional Descriptive Study.” Indian Journal of Public Health 64 (1): 22-26
Laxminarayan, R., B. Wahl, S. R. Dudala, K. Gopal, S. Neelima, K. J. Reddy, J.
Radhakrishnan, and J. A. Lewnard. 2020. “Epidemiology and Transmission
Dynamics of COVID-19 in Two Indian States.” Science 370 (6517): 691-697.
Levine, M. M., and O. S. Levine. 1997. “Influence of Disease Burden, Public
Perception, and Other Factors on New Vaccine Development, Implementation, and Continued Use.”The Lancet350 (9088): 1386-1392.
south AsiA vAccinAtes
Lin, Y., Z. Hu, Q. Zhao., H. Alias, M. Danaee, and L. P. Wong. 2020. “Understanding
COVID-19 Vaccine Demand and Hesitancy: A Nationwide Online Survey in
China.” PLoS Neglected Tropical Diseases, 14(12): e0008961.
Malani A., S Soman, S Ramachandran, A Chen, D Lakdawalla, S. Sudharshini, V. Prakash,
Y. Yogananth, S. Raju, and T.S. Selvavinayagam, 2021. “Vaccine Allocation Priorities
Using Disease Surveillance and Economic Data”, Mimeo, University of Chicago.
Malik, A. A., S. M. McFadden, J. Elharake, and S. B. Omer. 2020. “Determinants of COVID-19 Vaccine Acceptance in the US.” EClinicalMedicine, 26, 100495.
Mankiw, N. G. 2020. “Pay People to Get Vaccinated.” New York Times. 9 Sept. 2020
Marti, M., M. de Cola, N. E. MacDonald, L. Dumolard, and P. Duclos. 2017. “Assessments of Global Drivers of Vaccine Hesitancy in 2014–Looking Beyond Safety
Concerns.”PLOS One,12 (3). https://doi.org/10.1371/journal.pone.0172310
Maurer, J. 2009. “Who Has a Clue to Preventing the Flu? Unravelling Supply and
Demand Effects on the Take-Up of Influenza Vaccinations.” Journal of Health
Economics, 28 (3): 704-717.
Savulescu, J. 2021. “Good Reasons to Vaccinate: Mandatory or Payment for
Risk?”Journal of Medical Ethics,47 (2): 78-85.
Streatfield, K., M. Singarimbun, and I. Diamond. 1990. “Maternal Education and
Child Immunization.” Demography, 27 (3): 447-455.
Thakur, J., S. Prinja, C.C. Garg, S. Mendis and N. Menabde. 2011. “Social and
Economic Implications of Noncommunicable Diseases in India.” Indian
Journal of Community Medicine. 36 (5): 13-22.
World Health Organization. 2019. “Primary Health Care on the Road to Universal
Health Coverage, 2019 Monitoring Report.” Accessed March 25, 2021. https:// www.who.int/publications/i/item/primary-health-care-on-the-road-to-universal-health-coverage-2019-monitoring-report
World Health Organization. 2020. “WHO, National Regulators and Vaccine
Manufacturers in South-East Asia Region Discuss COVID-19 Vaccines.” Accessed
March 25, 2021. https://www.who.int/southeastasia/news/detail/11-12-2020who-national-regulators-and-vaccine-manufacturers-in-south-east-asia-regiondiscuss-covid-19-vaccines
SOUTH ASIA VACCINATES